Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Yingnian, Chen"'
Autor:
Jieling Jiang, Xiaofan Li, Dong Wu, Quanyi Lu, Kourong Miao, Houcai Wang, Xiaoping Li, Yingnian Chen, Shiyuan Zhou, Yali Zhou, Guiping Liao, Chuanhe Jiang, Xiaohong Yuan, Youshan Zhao, Chunkang Chang, Jie Chen, Han Zhu, Ruye Ma, Nainong Li, Xiaolin Yin, Xiaojin Wu, Sanbin Wang, Chun Wang, Jiong Hu
Publikováno v:
eJHaem, Vol 5, Iss 4, Pp 757-767 (2024)
Abstract Relapse remains the main cause of treatment failure in patients with myeloid malignancies even after allogeneic hematopoietic stem cell transplantation (allo‐HSCT). We observed a particularly low incidence of relapse in patients prepared w
Externí odkaz:
https://doaj.org/article/94ac479f3e48422e8c85d2f38c9f67db
Autor:
Shiqi Li, Zhongtao Yuan, Lin Liu, Yu Li, Le Luo, Lihui Peng, Mengli Xu, Ping Yin, Yingnian Chen, Xiaoping Li, Qingying Zang, Xi Zhang, Sanbin Wang
Publikováno v:
eJHaem, Vol 5, Iss 3, Pp 584-588 (2024)
Abstract CD7 targeted CAR‐T has demonstrated potential in the treatment of T cell malignancies but no study has been reported about its potential in the prophylaxis of GVHD in allo‐HSCT. Here we reported a special case that a boy diagnosed with r
Externí odkaz:
https://doaj.org/article/65d1117ca02440e58d921b557c836e0c
Autor:
Shiqi, Li, Jiasi, Zhang, Lvzhe, Chen, Huailong, Xu, Liping, He, Lin, Liu, Qianzhen, Zhang, Zhongtao, Yuan, Junjie, Shen, Zucong, Chen, Yingzi, Zhang, Meiling, Wang, Yunyan, Li, Linling, Wang, Lihua, Fang, Yingnian, Chen, Wei, Zhu, Yu, Li, Le, Luo, Youcheng, Wang, Dingsong, Zhang, Yancheng, Dong, Ping, Yin, Lihua, Zhang, Xiaoping, Li, Xiaozhuang, Hu, Zhongzheng, Zheng, Zhi, Yang, Cheng, Qian, Sanbin, Wang
Publikováno v:
In Molecular Therapy - Oncolytics 15 June 2023 29:107-117
Autor:
Shiqi Li, Xinxin Wang, Le Luo, Jia Liu, Jun Rao, Lin Liu, Li Gao, Zhongtao Yuan, Yu Li, Gui Li, Duanpeng Wang, Sheng Li, Jiaping He, Lihua Zhang, Lvzhe Chen, Ping Yin, Chunmin Li, Xiaoping Li, Youcheng Wang, Yancheng Dong, Dingsong Zhang, Lihua Fang, Yingnian Chen, Lianjun Shen, Wenling Li, Wei Cao, Xi Zhang, Sanbin Wang
T-cell acute lymphoblastic leukemia (T-ALL) represents an area of high unmet medical needs. Once relapsed, patients have limited treatment options and usually a poor prognosis. T-ALL antigens such as CD7 is extensively expressed in normal T cells and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2c74f7415b9928304f4f848f334e4d67
https://doi.org/10.21203/rs.3.rs-2431426/v1
https://doi.org/10.21203/rs.3.rs-2431426/v1
Autor:
Shiqi Li, Zhi Yang, Zucong Chen, Yu Li, Lin Liu, Zhongtao Yuan, Yingzi Zhang, Le Luo, Lihua Fang, Yingnian Chen, Qianzhen Zhang, Junjie Shen, Yunyan Li, Linling Wang, Meiling Wang, Wei Zhu, Sanbin Wang, Cheng Qian
Publikováno v:
Journal of Clinical Oncology. 40:7008-7008
7008 Background: CD19 chimeric antigen receptor (CAR) T cell therapy has shown promising efficacy in the r/r B-ALL. However, the life-threatening side effects especially high grades of cytokine release syndrome (CRS) and immune effector cell-associat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fb4f4d48b10f8598d2ce807800495149
https://doi.org/10.1200/jco.2022.40.16_suppl.7008
https://doi.org/10.1200/jco.2022.40.16_suppl.7008
Autor:
Lihua Fang, Dingsong Zhang, Xinxin Wang, Duanpeng Wang, Le Luo, Jia Liu, Cong Han, Yu Li, Zhimin Li, Wei William Cao, Lianjun Shen, Chunhui Yang, Jiaping He, Xun Ye, Lin Liu, Martina Sersch, Shiqi Li, Yingnian Chen, Sanbin Wang, Zhongtao Yuan, Yancheng Dong, Kun Wu, Youcheng Wang
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 27(5)
Purpose: Although chimeric antigen receptor T-cell (CAR-T) therapy development for B-cell malignancies has made significant progress in the last decade, broadening the success to treating T-cell acute lymphoblastic leukemia (T-ALL) has been limited.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::12f92446754b751a582ea53b3a41c204
https://pubmed.ncbi.nlm.nih.gov/33234511
https://pubmed.ncbi.nlm.nih.gov/33234511
Autor:
Yu Li, Xun Ye, Yu Han, Kun Wu, Youcheng Wang, Jianning Ge, Ruihao Huang, Xinxin Wang, Xi Zhang, Duanpeng Wang, Lei Gao, Lin Liu, Lihua Fang, Dingsong Zhang, Zhongtao Yuan, Yao Liu, Wei Cao, Sanbin Wang, Yingnian Chen, Le Luo, Chunhui Yang, Cheng Zhang, Xu Tan, Jiaping He, Shiqi Li, Zhimin Li, Jia Liu
Publikováno v:
Cancer Research. 80:CT052-CT052
Introduction: Patients with T cell malignancies usually have high relapse and mortality rates. Due to shared common surface antigen and potential contamination by malignant cells, development of CAR-T therapies for r/r T-ALL has been lagged, regardle
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bb5c53fc87e1b019f8f38b1ec21966f1
https://doi.org/10.1158/1538-7445.am2020-ct052
https://doi.org/10.1158/1538-7445.am2020-ct052